Key facts

Invented name
Tenkasi (previously Orbactiv)
Active substance
oritavancin diphosphate
Therapeutic area
Infectious diseases
Decision number
PIP number
Pharmaceutical form(s)
  • Powder for concentrate for solution for infusion
  • Age-appropriate dosage form for parenteral use
Condition(s) / indication(s)
Treatment of acute bacterial skin and skin structure infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Menarini International Operations Luxembourg S.A.

E-mail: prijli@menarini.it
Tel. +39 0555 680633

Decision type
PM: decision on the application for modification of an agreed PIP


Related content

How useful was this page?

Add your rating